Methylguanidine reduces the development of non septic shock induced by zymosan in mice

Life Sciences

Volumn 75, Issue 12, 2004, Pages 1417-1433

  Marzocco, Stefania ^a   Di Paola, Rosanna ^b   Genovese, Tiziana ^b   Sorrentino, Raffaella ^c   Britti, Domenico ^d   Scollo, Giuseppe ^e   Pinto, Aldo ^a   Cuzzocrea, Salvatore ^b   Autore, Giuseppina ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF TERAMO   (Italy)

^e Centro Cuore Morgagni   (Italy)

Author keywords

Methylguanidine; Nitric oxide; Organ injury; Peroxynitrite; Zymosan

Indexed keywords

ALKALINE PHOSPHATASE; AMYLASE; BILIRUBIN; CREATININE; METHYLGUANIDINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; RADICAL; TRIACYLGLYCEROL LIPASE; ZYMOSAN;

ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SCREENING; ENTERITIS; HISTOLOGY; IMMUNOREACTIVITY; INFLAMMATION; KIDNEY INJURY; LIVER INJURY; LUNG; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PANCREAS INJURY; PERITONEUM EXUDATE; PROTEIN DEGRADATION; REDUCTION; SEPTIC SHOCK; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; EXUDATES AND TRANSUDATES; IMMUNOHISTOCHEMISTRY; INTESTINES; KIDNEY; LIPID PEROXIDATION; LUNG; MALE; METHYLGUANIDINE; MICE; NEUTROPHILS; PANCREAS; PERITONITIS; PEROXIDASE; PEROXYNITROUS ACID; POLY(ADP-RIBOSE) POLYMERASES; SHOCK; TYROSINE; ZYMOSAN;

EID: 3042739639     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.02.031     Document Type: Article

References (59)

1. Autore G., Marzocco S., Sorrentino R., Mirone V.G., Baydoun A., Pinto A. In vitro and in vivo TNF-alpha synthesis modulation by methylguanidine, an uremic catabolyte. Life Sciences. 65(11):1999;121-127
2. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxil radical production by peroxynitrite: implications for endothelial injury from NO and superoxide. Proceedings of the National Academy of Science of USA. 87(4):1990;1620-1624
3. Crow J.P., Beckman J.S., McCord J.M. Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry. 34(11):1995;3544-3552
4. Cuzzocrea S., Zingarelli B., Sautebin L., Rizzo A., Crisafulli C., Campo G.M., Costantino G., Calapai G., Nava F., Di Rosa M., Caputi A.P. Multiple organ failure following zymosan-induced peritonitis is mediated by NO. Shock. 8(4):1997;268-275
5. Cuzzocrea S., Filippelli A., Zingarelli B., Falciani M., Caputi A.P, Rossi F. Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock. 7(5):1997;351-357
6. Cuzzocrea S., Zingarelli B., Calapai G., Nava F., Caputi A.P. Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Science. 60(3):1997;215-220
7. Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A.L., Caputi A.P., Szabo C. Role of peroxinitrite and activation of poly (ADP rybose) synthetase in the vascular failure induced by zymosan-activated plasma. British Journal Pharmacology. 122(3):1997;493-503
8. Cuzzocrea S., Costantino G., Mazzon E., Caputi A.P. Beneficial effects of raxofclast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in carrageenan-induced pleurisy. British Journal of Pharmacology. 126(2):1999;407-414
9. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacological Review. 53(1):2001;135-159
10. Damas J., Remacle-Volon G., Bourdon V. Platelet-activating factor and vascular effects of zymosan in rats. European Journal Pharmacology. 231(2):1993;231-236
11. Deitch E.A., Ma W.J., Ma L., Berg R.D., Specian R.D. Protein malnutrition predisposes to inflammatory-induced gut-origin septic states. Annals Surgery. 221(5):1990;560-568
12. Deitch E.A. Multiple organ failure. Pathophysiology and potential future therapy. Annals Surgery. 216(2):1992;117-134
13. Demling R., Nayac U., Ikegami K., LaLonde C. Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in the rats. Shock. 2(3):1994;222-227
14. Dinerman J.L., Lowenstein C.J., Snyder S.H. Molecular mechanism of nitric oxide production. Potential relevance to cardiovascolar disease. Circulation Research. 73(2):1993;217-222
15. Doherty N.S., Beaver T.H., Chan K.Y., Dinerstein R.J., Diekema K.A. The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species. British Journal Pharmacology. 101(4):1990;869-874
16. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391(6665):1998;393-397
17. Faist E., Baue A.E., Dittmer H., Herberer G. Multiple organ failure in polytrauma patients. Journal of trauma-injury infection and critical care. 23(9):1983;775-787
18. Fernandez P.M., Henson A., Otani A., Hugli T.E. Chemotactic response to human C3a and C5a anaphylatoxins: evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo condition. Journal Immunolology. 120(1):1978;109-115
19. Giovannetti S., Biagini M., Balestri P.L., Navalesi R., Giagnoni P., De Matteis A., Ferro-Milone P., Perfetti C. Uraemia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clinical Science. 36(3):1969;445-452
20. Goris R.J.A., Boekholtz W.K., van Bebber I.P., Nuytinck J.K., Schillings P.H. Multiple organ failure and sepsis without bacteria. Archivies of Surgery. 121(8):1986;897-901
21. Goris R.J.A., van Bebber I.P.T., Moller R.M.H., Koopman J.P. Dose selective contamination of the gastrointestinal tract prevent multiple organ failure? Archivies of Surgery. 126(5):1991;561-565
22. Halliwell B., Hoult J.R., Blake D.R. Oxidants, inflammation and anti-inflammatory drugs. FASEB Journal. 2(13):1988;2867-2873
23. Holmdahl R., Klareskog L., Rubin K., Larsson E., Wigzell H. T limphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scandinavian Journal of Immunology. 22(3):1985;295-306
24. Inoue S., Kawanishi S. Oxidative DNA damage induced by simultaneous generation NO and superox. FEBS Letters. 371(1):1995;86-88
25. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids. 36:2001;41-44. (Suppl)
26. Lentsch A.B., Shanley T.P., Sarma V. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. Journal Clinical Investigation. 100(10):1997;2443-2448
27. Lundberg C., Arfors K.E. Polymorphonuclear leukocyte accumulation in inflammatory dermal sites as measured by 51Cr-labeled cells and myeloperoxidase. Inflammation. 7(3):1983;247-255
28. MacAllister R.J., Whitley G.S., Vallance P. Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney International. 45(3):1994;737-742
29. Mainous M.R., Ertel W., Chaudry I.H., Deitch E.A. The gut: a cytokine-generating organ in systemic inflammation? Shock. 4(3):1995;193-199
30. Menichini G.C., Gonnella M., Barsotti G., Giovannetti S. Determination of methylguanidine in serum and urine from normal and uremic patients. Experientia. 27(10):1971;1157-1158
31. Metha J.L., Lawson D.L., Nicolini F.A., Ross M.H., Player D.W. Effect of activated polimorphonuclear leukocytes on vascular smooth muscle tone. American Journal of Phisiology. 261(2Pt2):1991;327-334
32. Moncada S., Higgs A. The L-arginine NO pathway. New England Journal of Medicine. 329(27):1993;2002-2012
33. Moncada S., Palmer R.M., Higgs E.A. NO: physiology, patophysiology and pharmacology. Pharmacological Review. 43(2):1991;109-142
34. Mullane K.M., Kraemer R., Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. Journal of Pharmacological Methods. 14(3):1985;157-167
35. Murohara T., Kugyyama K., Sugiyama S., Ohgushi M., Yasue H. Activated human polymorphonuclear leukocytes elicit endothelium-dependent contraction in isolated pig coronary arteries. Journal of Cardiovascular Pharmacology. 21(5):1993;760-766
36. Nathan C. Nitric oxide as a secretary product of mammalian cells. FASEB Journal. 6(12):1992;3051-3064
37. Rao A.V., Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutritional Neuroscience. 5(5):2002;291-309
38. Rao T.S., Currie J.L., Shaffer A.F., Isakson P.C. In vivo characterization of zymosan-induced mouse peritoneal inflammation. Journal of Pharmacology and Experimental Therapeutics. 269(3):1994;917-925
39. Sakamoto M., Aoyagi K., Nagase S., Ishikawa T., Takemura K., Narita M. Methylguanidine synthesis by active oxygen generated by stimulated human neutrophils. Nippon Jinzo Gakkai Shi. 31(8):1989;851-858
40. Salgo M.G., Squadrito G.L., Pryor W.A. Peroxinitrite causes apoptosis in rat thymorytes. Biochemical and Biophisical Research Communications. 215(3):1995;1111-1118
41. Salvemini D., Mazzon E., Dugo L., Riley D.P., Serraino I., Caputi A.P., Cuzzocrea S. Pharmacological manipulation of the inflammatory cascade by superoxide dismutase mimetic, M40403. British Journal Pharmacology. 132(4):2001;815-827
42. Salvemini D., Wang Z.Q., Bourdon D.M., Stern M.K., Currie M.G., Manning P.T. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. European Journal Pharmacology. 303(3):1996;217-220
43. Salvemini D., Wang Z.Q., Stern M.K., Currie M.G., Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proceedings of the National Academy of Science of USA. 95(5):1998;2659-2663
44. Shayevitz J.R., Miller C., Johnson K.J., Rodriguez J.L. Multiple organ dysfunction sindrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock. 4(6):1995;389-396
45. Snyderman J., Phillips F., Mergenhagen S.E. Polymorphonuclear leukocyte chemotactic activity in rabbit serum and guinea pig serum treated whit immune complexes. Evidence for C5a as the major chemotactic factor. Infection and Immunity. 134(5):1970;521-525
46. Sorrentino R., Sautebin L., Pinto A. Effect of methylguanidine, guanidine and structurally related compounds on constitutive and inducible nitric oxide synthase activity. Life Sciences. 61(13):1997;1283-1291
47. Southan G., Szabò C. Selective pharmacological inhibition of distinct NOS isoforms. Biochemical Pharmacology. 51(4):1996;383-394
48. Szabò C., Lim L.H.K., Cuzzocrea S., Getting S.J., Zingarelli B., Flower R.J., Salzman A.L., Perretti M. Inhibition of poly(ADP-ribose) sinthetase exerts antinflammatory effects and inhibits neutrophil recruitment. Journal of Experimental Medicine. 186(7):1997;1041-1049
49. Szabò C., Virag L., Cuzzocrea S., Scott G.S., Hake P., O'Connor M.P., Zingarelli B., Salzman A., Kun E. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proceedings of the National Academy of Science of USA. 95(7):1998;3867-3872
50. Szabò C. Alterations in the production of NO in various forms of circulatory shock. New Horizons. 3(1):1995;2-32
51. Szabò C. Role of poly(ADP-ribose) synthetase in inflammation. European Journal Pharmacology. 350(1):1998;1-19
52. Teixeiera T.J., Williams P.G., Hellewell P.G. Role of prostaglandines and nitric oxide in acute inflammatory reactions in guinea-pig skin. British Journal Pharmacol. 110(4):1993;1515-1521
53. van Bebber I.P., Boekholtz K.F., Goris R.J.A., Schillings P.H., Dinges H.P., Bahrami S., Redl H., Schlag G. Neutrophil function and lipid peroxidation in rat model in rat model of multiple organ failure. Journal of Surgical Research. 47(6):1989;471-475
54. van Bebber I.P., Lieners C.F.J., Koldewijn E.L., Redl H., Goris R.J.A. Superoxide dismutase and catalase in an experimental model of multiple organ failure. Journal of Surgical Research. 52(3):1992;265-270
55. Vane J., Botting R. Inflammation and mechanism of action of antinflammatory drugs. Analytical Biochemistry. 1(2):1987;89-96
56. Von Asmuth E.J.U., Meassen I.G., Van der Linden C.J., Buurman W.A. Tumor necrosis factor alpha (TNF?) and interkeukin 6 in zymosan-induced shock model. Scandinavian Journal of Immunology. 34(2):1991;197-206
57. Wang P., Wu P., Siegel M.I. Interleuchin (IL)-10 inhibits nuclear factor KB (NF-B) activation in human monocytes. IL 10 and IL 4 suppress cytokine synthesis by different mechanism. Journal of Biological Chemistry. 270(16):1995;9558-9563
58. Yamada T., Grisham M.B. Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation. Klinische Wochenschrift. 69(21-23):1991;988-994
59. Zhang G.L., Wang Y.H., Teng H.L., Lin Z.B. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World Journal of Gastroenterology. 7(3):2001;331-334